首页 | 本学科首页   官方微博 | 高级检索  
     


Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
Authors:Yasuhito Tanaka  Anthony E.T. Yeo  Etsuro Orito  Kiyoaki Ito  Noboru Hirashima  Tatsuya Ide  Michio Sata  Masashi Mizokami
Affiliation:(1) Department of Clinical Molecular Informative Medicine, Nagoya City University Medical School Graduate School of Sciences, Kawasumi 1, Mizuho, Nagoya, 467-8601, Japan;(2) Jacobus Pharmaceutical Company, Princeton, New Jersey, USA;(3) Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;(4) Department of Gastroenterology, Chukyo Hospital, Nagoya, Japan;(5) Second Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan
Abstract:
Keywords:hepatitis B virus  lamivudine  breakthrough hepatitis  pre-S deletion mutation  precore mutation
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号